Genetic Technologies
GENE
$2.44
Share price
-22.78%
Change (1 day)
117.86%
Change (1 year)
Categories
P/S ratio for Genetic Technologies (GENE)
P/S ratio as of April 2024 (TTM): 0.7079
According to Genetic Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.707916. At the end of 2008 the company had a P/S ratio of 1.85.
P/S ratio history for Genetic Technologies from 2005 to 2008
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2008 | 1.85 | -40.16% |
| 2007 | 3.09 | -78.5% |
| 2006 | 14.4 | -21.63% |
| 2005 | 18.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.87 | 588.53% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 1.52 | 115.31% | 🇺🇸 USA |
 Danaher DHR | 7.42 | 948.24% | 🇺🇸 USA |
 LabCorp LH | 1.30 | 84.19% | 🇺🇸 USA |
 Compugen CGEN | 5.08 | 618.17% | 🇮🇱 Israel |
 Neogen NEOG | 2.83 | 299.75% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.22 | 214.19% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 171 | 24,064.17% | 🇺🇸 USA |